Skip to main content
. 2016 Dec 16;95(50):e5601. doi: 10.1097/MD.0000000000005601

Figure 3.

Figure 3

Forest plot of comparison for overall survival (A) and overall survival rate (B) between EGFR-TKIs and taxanes in NSCLC. EGFR-TKI = epidermal growth factor receptor tyrosine kinase inhibitor, NSCLC = nonsmall-cell lung cancer, OS = overall survival, OSR = overall survival rate.